These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3294253)

  • 1. Monoclonal antibody 14E identifies the oligodendrocyte cell body in normal adult human and rat white matter.
    Newcombe J; Cuzner ML
    J Neuroimmunol; 1988 Aug; 19(1-2):11-20. PubMed ID: 3294253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody 14E recognizes an antigen common to human oligodendrocytes, Schwann cells, Bergmann glia, and a subpopulation of reactive glia.
    Newcombe J; Naik N; Cuzner ML
    Neurochem Res; 1992 Sep; 17(9):933-8. PubMed ID: 1407280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrimination between different types of neuroglial cells in rat central nervous system using combined immuno- and enzyme-histochemical methods.
    de Groot CJ; Dijkstra CD; Sminia T
    Immunobiology; 1988 Dec; 178(3):177-90. PubMed ID: 2465992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to oligodendroglia in patients with multiple sclerosis.
    Abramsky O; Lisak RP; Silberberg DH; Pleasure DE
    N Engl J Med; 1977 Dec; 297(22):1207-11. PubMed ID: 335246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocytes, oligodendrocytes, and Schwann cells share a common antigenic determinant that cross-reacts with myelin basic protein: identification with monoclonal antibody.
    Brenner T; Lisak RP; Rostami A; Pleasure DE; Silberberg DH
    J Neurosci; 1986 Jul; 6(7):1925-33. PubMed ID: 2426423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease.
    Schluesener HJ; Sobel RA; Linington C; Weiner HL
    J Immunol; 1987 Dec; 139(12):4016-21. PubMed ID: 3500978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Killing of rat glial cells by complement: deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis.
    Piddlesden SJ; Morgan BP
    J Neuroimmunol; 1993; 48(2):169-75. PubMed ID: 7693753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to isolated oligodendrocytes.
    Abramsky O; Lisak RP; Silberberg DH; Brenner T; Pleasure D
    J Neurol Sci; 1979 Sep; 43(1):157-67. PubMed ID: 521826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological aspects of demyelination.
    Steck AJ
    Bull Schweiz Akad Med Wiss; 1981-1982; ():109-12. PubMed ID: 6191816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of expression of OKT8 antigen on cultured human, calf and rat oligodendrocytes.
    Hirayama M; Lisak RP; Kim SU; Pleasure DE; Silberberg DH
    Nature; 1983 Jan; 301(5896):152-4. PubMed ID: 6185848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do patients with demyelinating disease have antibodies against human glial cells in their sera?
    Kennedy PG; Lisak RP
    J Neurol Neurosurg Psychiatry; 1981 Feb; 44(2):164-7. PubMed ID: 7012279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The glial framework of central white matter tracts: segmented rows of contiguous interfascicular oligodendrocytes and solitary astrocytes give rise to a continuous meshwork of transverse and longitudinal processes in the adult rat fimbria.
    Suzuki M; Raisman G
    Glia; 1992; 6(3):222-35. PubMed ID: 1478731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocyte and oligodendrocyte distribution in adult rat cerebellum: an immunohistological study.
    Ghandour MS; Vincendon G; Gombos G
    J Neurocytol; 1980 Oct; 9(5):637-46. PubMed ID: 6777466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid precursor protein (APP) expression in multiple sclerosis lesions.
    Gehrmann J; Banati RB; Cuzner ML; Kreutzberg GW; Newcombe J
    Glia; 1995 Oct; 15(2):141-51. PubMed ID: 8567065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodies.
    Scolding NJ; Morgan BP; Houston A; Campbell AK; Linington C; Compston DA
    J Neurol Sci; 1989 Feb; 89(2-3):289-300. PubMed ID: 2926453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligodendrocytes: the putative target cells of multiple sclerosis.
    Abramsky O
    Isr J Med Sci; 1982 Jan; 18(1):149-58. PubMed ID: 7040297
    [No Abstract]   [Full Text] [Related]  

  • 17. Oligodendrocyte cell surface recognized by a novel monoclonal antibody specific to sulfatide.
    Ghandour MS; Nussbaum JL
    Neuroreport; 1990 Sep; 1(1):13-6. PubMed ID: 1717035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new oligodendrocyte specific plasma membrane surface protein identified by a monoclonal antibody produced in vitro.
    Birling MC; Nussbaum F; Nussbaum JL
    J Neurosci Res; 1994 Aug; 38(5):538-50. PubMed ID: 7815472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of astrocytes and newly formed oligodendrocytes in resolving multiple sclerosis lesions.
    Prineas JW; Kwon EE; Goldenberg PZ; Cho ES; Sharer LR
    Lab Invest; 1990 Nov; 63(5):624-36. PubMed ID: 1700195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sulfatide-reactive human monoclonal antibody obtained from a multiple sclerosis patient selectively binds to the surface of oligodendrocytes.
    Kirschning E; Rutter G; Uhlig H; Dernick R
    J Neuroimmunol; 1995 Feb; 56(2):191-200. PubMed ID: 7860714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.